Latest Emergency Use Authorization Stories
SALT LAKE CITY, Feb.
PLEASANTON, Calif., Dec. 29, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S.
HILDEN, Germany and GERMANTOWN, Maryland, December 4, 2014 /PRNewswire/ -- - New molecular diagnostic test detects but does not differentiate all
NEW YORK, Oct. 27, 2014 /PRNewswire/ -- Kalorama Information says that PCR is demonstrating its worth in the recent Ebola concern in the United States and is the dominant test for the virus.
MADISON, N.J., and CYPRESS, Calif., May 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S.
CAMBRIDGE, Mass., March 24 /PRNewswire/ -- IMDx announced today that its IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
SAN ANTONIO, Feb. 22 /PRNewswire/ -- Longhorn Vaccines & Diagnostics today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay(TM) in CLIA high complexity laboratories. .
ST. GEORGE, Utah, Dec. 14 /PRNewswire/ -- DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA's GeneSTAT(TM) detection platform.
MADISON, N.J., Nov.
SILVER SPRING, Md., Nov. 2 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today published a guidance document that should help manufacturers develop diagnostic tests for the 2009 H1N1 influenza virus.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).